New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
19th July 2024
26th June 2024
14th May 2024
12th April 2024
8th January 2024
13th December 2023
5th December 2023
8th November 2023
7th November 2023
17th August 2023
4th August 2023
13th July 2023
US - Ohio: The State Medical Board of Ohio (SMBO) has voted to include irritable bowel syndrome (IBS) as a qualifying condition in the Ohio Medical Marijuana Control Program (OMMCP), expanding the total number of qualifying conditions to 26. The decision is effective immediately, allowing individuals with IBS to access medical cannabis for therapeutic purposes. However, the board rejected petitions to include autism spectrum disorder and obsessive-compulsive disorder (OCD) as qualifying conditions in the programme.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.